Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?

Author： Antovic J. P.   Schulman S.   An S. S. A.   Greenfield R. S.   Blombäck M.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.64, Iss.8, 2004-11, pp. : 745-752

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombin activatable fibrinolysis inhibitor (TAFI)—How does thrombin regulate fibrinolysis?

By Bouma Bonno   Mosnier Laurent  

Annals of Medicine, Vol. 38, Iss. 6, 2006-10 ,pp. : 378-388

Informa Healthcare

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 257-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 256-257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 260-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 259-259

John Wiley & Sons Inc

Access to resources Recommend Favorite